4.5 Article

Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry

Journal

Publisher

BMC
DOI: 10.1186/1532-429X-14-40

Keywords

Pulmonary hypertension; Cardiovascular magnetic resonance; Ventricular mass index; Late gadolinium enhancement; Left heart disease; Pulmonary arterial hypertension; Right ventricle

Funding

  1. Pfizer
  2. Bayer
  3. unrestricted educational grant from Actelion
  4. Actelion
  5. GSK
  6. Encysive
  7. United Therapeutics
  8. GE
  9. Lilley
  10. National Institute for Health Research (NIHR) via its Biomedical Research Units funding scheme
  11. Engineering and Physical Sciences Research Council (EPSRC)
  12. National Institute for Health Research [BRF-2011-023] Funding Source: researchfish
  13. National Institutes of Health Research (NIHR) [BRF-2011-023] Funding Source: National Institutes of Health Research (NIHR)

Ask authors/readers for more resources

Background: Cardiovascular Magnetic Resonance (CMR) imaging is accurate and reproducible for the assessment of right ventricular (RV) morphology and function. However, the diagnostic accuracy of CMR derived RV measurements for the detection of pulmonary hypertension (PH) in the assessment of patients with suspected PH in the clinic setting is not well described. Methods: We retrospectively studied 233 consecutive treatment naive patients with suspected PH including 39 patients with no PH who underwent CMR and right heart catheterisation (RHC) within 48hours. The diagnostic accuracy of multiple CMR measurements for the detection of mPAP >= 25 mmHg was assessed using Fisher's exact test and receiver operating characteristic (ROC) analysis. Results: Ventricular mass index (VMI) was the CMR measurement with the strongest correlation with mPAP (r = 0.78) and the highest diagnostic accuracy for the detection of PH (area under the ROC curve of 0.91) compared to an ROC of 0.88 for echocardiography calculated mPAP. Late gadolinium enhancement, VMI >= 0.4, retrograde flow >= 0.3 L/min/m(2) and PA relative area change <= 15% predicted the presence of PH with a high degree of diagnostic certainty with a positive predictive value of 98%, 97%, 95% and 94% respectively. No single CMR parameter could confidently exclude the presence of PH. Conclusion: CMR is a useful alternative to echocardiography in the evaluation of suspected PH. This study supports a role for the routine measurement of ventricular mass index, late gadolinium enhancement and the use of phase contrast imaging in addition to right heart functional indices in patients undergoing diagnostic CMR evaluation for suspected pulmonary hypertension.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available